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Abstract 22 
Osteoarthritis (OA) is the most common age-related joint disorder in man. MicroRNAs 23 
(miRNA), a class of small non-coding RNAs are potential therapeutic targets for regulating 24 
molecular mechanisms in both disease and ageing. Whilst there is an increasing amount of 25 
research on the roles of miRNAs in ageing, there has been scant research on age-related 26 
changes in miRNA in cartilage. We undertook a microarray study on young and old human 27 
cartilage. Findings were validated in an independent cohort. Contrasts between these samples 28 
identified twenty differentially expressed miRNAs in cartilage from old donors, derived from 29 
an OA environment which clustered based on OA severity. We identified a number of 30 
recognised and novel miRNAs changing in cartilage ageing and OA including miR-126; a 31 
potential new candidate with a role in OA pathogenesis. These analyses represent important 32 
candidates that have the potential as cartilage ageing and OA biomarkers and therapeutic 33 
targets.  34 
 35 
1. Introduction 36 
Osteoarthritis (OA) is the most common degenerative disease of joints affecting 37 
approximately 10% and 18% of men and women, respectively, over the age of 60 years [1]. It 38 
mainly affects the hands, knees and hips with symptoms including pain, joint stiffness and 39 
movement impairment leading to reduced quality of life [2]. The molecular mechanisms of 40 
OA though not fully understood are related to abnormal joint metabolism and an imbalance 41 
between anabolic and catabolic processes [3]. This imbalance leads to pathological changes 42 
in the joint. These present mainly as thinning and progressive degradation of articular 43 
cartilage; the connective tissue that protects the joint from friction and mechanical load injury 44 
[4]. Other pathological changes include thickening of the subchondral bone, inflammation of 45 
the synovium, and formation of osteophytes [5]. Current treatments are aimed principally at 46 
relieving the symptoms rather than treating the disease.  However, many patients ultimately 47 
undergoing joint replacement surgery for end-stage OA. This is because the molecular 48 
mechanisms underlying this heterogeneous, age-related disease are poorly characterized.  49 
OA is a multifactorial disease with known risk factors including genetics [6], sex, obesity and 50 
joint injury [7]. However, the most common risk factor is age [5]. The progression and 51 
initiation of OA is facilitated by numerous stimuli and circumstances including changes in 52 
the homeostatic balance due to age. Age-related cell-senescence can affect chondrocyte 53 
homeostasis and metabolism, by increasing the expression of enzymes such as matrix 54 
metalloproteinases and aggrecanases, which break down the extracellular matrix of cartilage; 55 
promoting OA development [8]. Additionally, age-related inflammation (termed inflamm-56 
ageing) promotes the expression of cell-signalling molecules, such as interleukins and other 57 
cytokines. These  act as mediators of matrix degradation, contributing to OA progression [9].  58 
 59 
MicroRNAs (miRNAs or miRs) are short (~22nt) non-coding RNAs. They  have emerged as 60 
critical cell homeostasis regulators which function through post-transcriptional modulation of 61 
gene expression by binding and repressing the expression of specific mRNAs targets [10]. 62 
MiRNA genes are found within intergenic or intragenic regions, and are transcribed into 63 
double-stranded stem-loop structures called the primary transcript. The primary transcript is 64 
processed by the microprocessor complex, consisting of the ribonuclease DROSHA, and 65 
DiGeorge syndrome critical region 8 protein into precursor miRNAs which are exported in 66 
the cytoplasm through Exportin-5 [11]. Precursor miRNAs are incorporated into the RNA-67 
induced silencing complex. These are cleaved further by the endoribonuclease Dicer to form 68 
the single-stranded mature miRNA [12]. MiRNA-mediated expression is accomplished 69 
through perfect or imperfect complementarity between the miRNA and the mRNA target. 70 
Ultimately in animals this leads to inhibition of translation, mRNA degradation, or both [13]. 71 
 72 
It is estimated that one third of human genes are targeted by miRNAs [14]. This makes 73 
miRNAs potential therapeutic targets for regulating both disease and ageing molecular 74 
mechanisms. Indeed, several miRNAs have been found to play an important role in cartilage 75 
development and homeostasis and dysregulation of specific miRNAs has been linked to OA 76 
[15-17]. This  suggests miRNAs as feasible novel candidates for OA treatment targets and 77 
clinical biomarkers [18] . However, whilst there has been an increasing number of studies 78 
interrogating specific miRNAs as regulators of cartilage-specific processes in OA [19], few 79 
studies have assessed the contribution of cartilage ageing in the miRNA dysregulation 80 
evident in OA. One study found an age-related increase in miR-199a-3p and miR-193b 81 
contributing to a downregulation in collagen type II, aggrecan and SOX9, along with reduced 82 
proliferation and a reduction in miR-320c [17]. MiR-24, which regulates p16INK4a, was 83 
found to link age-related senescence and chondrocyte terminal differentiation-associated 84 
matrix remodelling in OA [20]. Furthermore, Miyaki et al observed that miR-140 null mice 85 
developed an age-related OA-like pathology due to elevated Adamts-5 [16].  86 
 87 
Our previous studies have identified age-related changes in miRNAs in tendon [21], bone 88 
marrow-derived mesenchymal stem cells [22], chondrocytes engineered from MSCs [23] and 89 
cartilage [24]. In this study we investigated, for the first time, miRNA expression in ageing 90 
knee cartilage in order to understand further cartilage ageing, and determine how this may 91 
contribute to OA. Establishing miRNAs differentially expressed in joints or cartilage during 92 
ageing and/or OA can provide basis for functional studies and potentially lead to 93 
development of novel, miRNA-based interventions against cartilage and joint degeneration 94 
during ageing and OA. 95 
 96 
2. Materials and Methods 97 
All reagents were from Thermo-Fisher-Scientific, unless stated. 98 
2.1 Samples 99 
For microarray analysis femoral intercondylar notch full thickness cartilage from male human 100 
knee cartilage of young (n=6; mean age ±SD 22.7±4.1 years) normal, collected at the time of 101 
anterior cruciate ligament repair and male old n=6; (66.4±15.9 years) OA human knees, at the 102 
time of total knee arthroplasty. For qRT-PCR validation an independent cohort was used 103 
which consisted of young knee cartilage from the intercondylar notch n=9 (mean age ±SD 104 
23.7+-3.8, old ‘normal’ cartilage from the lateral femoral condyle n=5 (68.6±3.8), and old 105 
OA cartilage n=8 (63.1±8.1) from the medial femoral condyle cartilage. All old specimens 106 
came from patients with a diagnosis of OA on pre-operative knee radiographs using Kellgren 107 
and Lawrence Scoring [25]. All cartilage taken was macroscopically normal. Medical ethics 108 
permission was received (Maastricht University Medical Centre approval IDs: MEC 08-4-109 
028 and 14-4-038). 110 
 111 
2.2 RNA isolation  112 
RNA was extracted from cartilage once pulverised into a powder with a dismembranator 113 
(Mikro-S, Sartorius, Melsungen, Germany) under liquid nitrogen Total RNA was extracted 114 
using the mirVana RNA isolation kit (Life Technologies, Paisley, UK) according to 115 
manufacturer’s instructions. RNA samples were quantified using a Nanodrop 116 
spectrophotometer (NanoDrop Technologies, Wilmington, USA). The integrity of the RNA 117 
was assessed on the Agilent 2100 Bioanalyser system using an RNA Pico chip. 118 
 119 
2.3 Microarrays 120 
600-900 ng of total RNA was labelled using the Affymetrix Flash-Tag Biotin HSR RNA 121 
labelling kit according to manufacturer’s instructions. Following Flash-Tag labelling the 122 
biotin-labelled samples were stored at -20
0
C prior to hybridisation onto Affymetrix GeneChip 123 
miRNA 4.0 for 17.5 hours at 48
0
C 60rpm in an Affymetrix hybridisation oven 645. 124 
Following hybridisation the arrays were washed using Affymetrix Hybridisation wash and 125 
stain kit on the GeneChip Fluidics station 450 using fluidics script FS450_0002, and scanned 126 
using the Affymetrix GeneChip scanner 3000 7G. 127 
2.4 Data analysis 128 
.CEL files were generated using the Affymetrix GeneChip Command Console Software, and 129 
Expression Console software used to quality control array performance. The miRNA 130 
expression data measured using Affymetrix miRNA 4.0 arrays were preprocessed using 131 
Affymetrix Expression Console with optioned method RMA for data normalisation [26]. The 132 
further statistical analyses were carried out on the 2578 miRNA probe set for Homo sapiens 133 
extracted from all probes and was used to determine both the detected and differentially 134 
expressed (DE) miRNAs. 135 
 136 
The presence of each probe in young and old samples were tested. In each test the p-value of 137 
six samples were combined using Fisher’s combined p-value methods. 138 
The expression was de-replicated to transcript level by averaging replicated probes. The   p-139 
value associated with the presence of de-replicated expression were assigned by combining 140 
the replicated probes using Fisher's combined p test.   141 
 142 
The DE analyses on contrasting two sample conditions were performed through linear models 143 
using limma package in R environment [27]. The significance of log fold change (logFC) 144 
values for miRNAs were evaluated using t-tests, the p-values associated with logFC values 145 
were adjusted for multiple testing using the False Discovery Rate (FDR) approach [28]. 146 
Significantly DE were defined as those with an FDR-adjusted P-value < 5%.  Sequence data 147 
have been submitted to National Centre for Biotechnology Information Gene Expression 148 
Omnibus (NCBI GEO); E-MTAB-5715. 149 
 150 
2.5 Integrated miR-mRNA analysis and functional enrichment analysis 151 
 In order to identify putative miRNA targets bioinformatics analysis was performed by 152 
uploading DE miRNA data into the MicroRNA Target Filter module within Ingenuity 153 
Pathway Analysis software (IPA, Qiagen Redwood City, CA, USA) to produce a network of 154 
potential miRNA gene targets. Targets were then filtered on a confidence of experimentally 155 
observed or highly predictive and on the cell chondrocyte. ToppGene was used for functional 156 
enrichment analysis of the miRNA targets using ToppGene [29] with a Bonferroni FDR of 157 
less than 0.05. Biological process gene ontology (GO) terms and associated FDR values 158 
generated through ToppGene were then summarised, and the network visualised using 159 
REViGO [30] and  Cytoscape [31]. 160 
 161 
2.6 Real-time polymerase chain reaction (qRT-PCR) 162 
Validation of the microarray analysis results in the dependent and independent cohorts of 163 
human knee cartilage samples was carried out using real-time quantitative PCR (qRT-PCR) 164 
analysis. Total RNA was extracted and quantified as above. cDNA was synthesized using 165 
200ng RNA and the miScript II RT Kit according to the manufacturer’s protocol (Qiagen, 166 
Crawley,UK). qPCR mastermix was prepared using the miScript SYBR Green PCR Kit 167 
(Qiagen, Crawley, UK) and the appropriate miScript Primer Assay (Qiagen, Crawley, UK) 168 
(Supplementary file 1) using 1ng/μl cDNA according to manufacturer’s guidelines.  Real-169 
time PCR was undertaken using an Applied Biosystems 7300 Real-Time PCR System 170 
(Applied Biosystems, Paisley, Scotland, UK). Relative expression levels were normalised to 171 
U6 snoRNA and calculated using the 2
-ΔCt
 method [32] .  172 
 173 
2.7 Statistical analysis 174 
For statistical evaluation of qRT-PCR results a Mann-Whitney test was performed using 175 
GraphPad Prism version 7.03 for Windows, (GraphPad Software, La Jolla California USA, 176 
www.graphpad.com); p-values are indicated. 177 
 178 
3. Results 179 
3.1 Microarray analysis overview 180 
 181 
A data quality assessment report generated revealed that the quality of the data was good and 182 
consistent for all 12 arrays. The distribution for log expression signal were highly similar in 183 
signal distribution, and using a boxplot for relative log expression signal  no arrays were 184 
outliers (data not shown). The outcomes of variation assessment were visualised in Figures 1a 185 
and b. Young samples correlated closely together. However old samples clustered into three 186 
distinct groupings as demonstrated by the correlation coefficient matrix heatmap (Figure 1a). 187 
Principal Component Analysis (PCA) plot of the log expression signal for 12 arrays revealed 188 
that samples from young were clustered tightly together and could be separated from the old 189 
samples. However, samples from the old group scattered in a very wide range as three sub-190 
populations. Samples 7, 8 and 10 (cluster 1) were more similar to samples from the young 191 
group and had the lowest KL scores; 1. Cluster 2 consisting of samples 11 and 12 and had KL 192 
scores of 4 and sample 9 had KL score of 2 (Figure 1b). Based on the multi-dimensional 193 
scaling (MDS) plot, subsequently four different selections of old samples were made and 194 
compared to young samples generating four results sets of DE analysis. Selection 1 includes 195 
all 6 old samples, selection 2 includes O_7, O_8, O-10, O_11, O_12, selection 3 includes 196 
O_9, O_11, O_12, and selection 4 includes O_7, O_8, O_10.   197 
 198 
3.2 miRNA expression profiling and dysregulation 199 
 200 
Of the 2578 human miRNAs represented on the Affymetrix GeneChip miRNA-4.0 201 
microarray, 303 and 416 were detected above background in young and old samples, 202 
respectively (Supplementary file 2). Using a cut-off of false discovery adjusted p-value <0.05 203 
for selection 1 there were 20 DE miRNAs (Figure 2 and Table 1), for selection 2 there were 204 
22 DE, for selection 3 there were 189 DE (Supplementary file 3) and for selection 4 there 205 
were 10 DE (Table 2).  206 
 207 
3.3 Identification of potential target genes of DE miRNAs   208 
 209 
In order to investigate the position of the DE miRNAs in the chondrocyte expression network 210 
we determined their putative target genes using IPA. This was undertaken for two datasets (1) 211 
selection 1; the DE miRNAs derived from all young samples compared to all old samples, 212 
and (2) those from young versus selection 4 (representing only old samples with lowest K&L 213 
scores) as we hypothesise this set is most likely to be predominantly age-related changes. 214 
These presumed mRNAs were input into a gene ontology and visualised. (1) Putative target 215 
genes regulated by 11 of the 20 the DE miRNAs were identified from the dysregulated genes 216 
in selection 1 (all young versus all old) in order to determine the functional significance. The 217 
microRNA target filter in IPA was used to integrate computational algorithms with multiple 218 
miRNA databases (Supplementary file 4).  These presumed mRNAs were input into the gene 219 
ontology tool ToppGene and then biological processes visualised in Revigo and Cytoscape 220 
(Figure 3a). The top biological processes were skeletal tissue development (FDR 9.29E11), 221 
regulation of cell proliferation (FDR 9.29E11) and ossification (FDR 1.18E9) 222 
(Supplementary file 3). The young samples compared to selection 4 gave putative target 223 
genes for six of the 10 DE miRNAs (Supplementary file 5). Biological processes are 224 
visualised in Figure 3b and the complete list in Supplementary file 5. The main biological 225 
processes were skeletal system development (FDR 3.15E07), homeostatic process (6.84E07) 226 
and positive regulation of signalling (6.22E06). 227 
 228 
3.4 qRT-PCR validation of miRNAs 229 
To validate the changes in miRNA expression detected by microarray platform, qRT-PCR 230 
analyses using RNA from both dependent (original RNA extracted from the young normal 231 
and old OA donors used in microarray analysis) and independent cohorts were performed. An 232 
independent cohort was selected based on samples with equivalent K&L scores to the 233 
samples used in the microarray.  For the independent cohort the K&L scores from young 234 
donors was 0, the old donors were (mean±SD) old ‘normal’ 1.3±0.9, and old OA 3.0±0.8.  235 
 236 
For the dependant cohort 10 DE miRNAs from the contrast young normal vs selection 3 were 237 
selected as we decided to focus on miRNA changes due to age and OA (Table 3).The  238 
expression of miRNAs: miR- 126-3p, -200c-3p, -424-3p and  -483-5p was significantly lower 239 
in old OA samples compared to young normal samples (Supplementary file 6A) confirming 240 
microarray results. However the expression of miRs:  146-5p, -424-3p, -181-5p, -Let 7f-1-3p, 241 
-Let 7b-5p, -150-5p, -21-5p, although following the same pattern of expression change 242 
between the two groups as in microarray analysis, did not reach significance (Supplementary 243 
file 6B).  244 
To further validate the results of the microarray analysis, we performed qRT-PCR analysis of 245 
the expression of miRs: -21-5p, -146a-5p, -181a-5p and -483a-5p on an independent cohort 246 
of samples (young normal compared to old OA). These miRNAs were chosen based on the 247 
fold change of their expression (by microarray), predicted or validated target gene set and/or 248 
known or predicted function in cartilage maintenance and degradation. The expression of all 249 
miRNAs tested was significantly lower in old OA samples compared to young normal 250 
samples (Figure 4A). This was in agreement with results from the dependent cohort. 251 
Additionally in young normal compared to old ‘normal’ cartilage the miRs -126 and -424 252 
were validated as reduced in expression in old normal samples in agreement with microarray 253 
results (Figure 4B).  254 
  255 
4. Discussion 256 
A strong  correlation exists between the age of an organism and OA, whilst ageing has a clear 257 
effect on cartilage gene expression [24]. One potential mechanism capable of regulating 258 
global alterations to a particular tissue is modification to the miRNA system. MiRNAs appear 259 
to control ageing at the level of organism lifespan, tissue and cellular senescence. The 260 
expression of many miRNAs has been demonstrated to be significantly altered with ageing. 261 
Indeed, many of these miRNAs have been identified as regulators of ageing at each of these 262 
levels. To begin to elucidate the role that miRNAs play in the global changes observed in 263 
cartilage with ageing, we undertook a microarray analysis of young and old human cartilage. 264 
Sex-related alterations were mitigated with the use of samples from males only. We identified 265 
unique signatures which were altered with ageing and/or OA as we characterised the 266 
expression of miRNAs in knee cartilage ageing as well as DE miRNAs dependant on the 267 
severity of OA (as determined by K&L score).   268 
 269 
In the initial microarray study cartilage samples were removed from the femoral 270 
intercondylar notch in both young and old donors. This site was selected as we had access to 271 
this tissue from both donor groups.  We recognise that a limitation of the study is that 272 
although the cartilage was taken from a macroscopically normal area in the old donors, this 273 
was from an OA joint environment. Furthermore, in order to validate our microarray results 274 
we used both the dependant cohort (to validate the platform) and an independent cohort to 275 
further validate some of our DE miRNAs in additional biological donors. Samples collected 276 
from old donors for the latter experiment where removed from the protected (lateral; 277 
described here as old normal) or unprotected (medial; described here as old OA) condyles 278 
following TKA.  279 
 280 
Our initial microarray analysis determined 20 DE miRNAs. However, the old donors 281 
clustered in three groups which correlated with the severity of K&L scores. We therefore 282 
repeated the microarray analysis with each of the clusters removed. In the analysis ‘selection 283 
4’ the samples which were most different from young (with the highest K&L scores) were 284 
removed identifying ten DE miRNAs.  We hypothesize these miRs represent the most likely 285 
dysregulated miRNAs principally due to age.  These were miR- 486-5p, -210, -4521, let-7a-1, 286 
-423-5p, -6795-5p, -6774-5p, -7111-5p, -6824-5p and -6875-5p.  Next we used TargetScan to 287 
find miRNA putative target genes.  Gene ontology was then undertaken on these genes in an 288 
effort to explore the position of the DE miRNAs in the chondrocyte expression network and 289 
cartilage ageing. In both the contrast between all young and all old samples, and young 290 
versus ‘selection 4’ (most likely affected by age or low K&L score), we identified significant 291 
biological processes. These included changes in apoptosis and cell proliferation, metabolism 292 
and homeostasis, and response to stimulus (altered nutrient sensing).  Processes such as 293 
altered nutrient sensing, and changes to homeostasis are some of  the hallmarks of cell ageing 294 
[7].  In young samples compared to ‘selection 4’ we identified two miRNAs which are known 295 
to interact with ageing pathways. These were Let-7 (cellular senescence and stem cell 296 
exhaustion) and miR-486 ( altered nutrient sensing) [33]. Additionally, Let-7 and miR-486 297 
(which affect protein synthesis and mitochondrial function) have previously been identified 298 
as reduced in muscle ageing [34].  299 
 300 
The clustering of old samples into subgroups was expected. This was as it is accepted that 301 
although cartilage may appear grossly normal, its gene and protein expression can be affected 302 
when it is in an OA environment. Indeed, we have previously described that transcriptomes 303 
from chondrocytes in late-stage OA are similar whether cartilage is harvested from intact 304 
(protected, generally the lateral femoral condyle) or fibrillated (unprotected, generally the 305 
medial femoral condyle) areas within the knee [35]. However others have described that in 306 
cartilage gene expression changes are evident in different stages of OA [36, 37]. One problem 307 
with the identification of clusters apparently relating to the K&L scores was that this reduced 308 
the power of the study. Furthermore, when attempting to validate the results of the microarray 309 
with the dependant cohort using qRT-PCR this led to large variations within the old donor 310 
groups. Higher variations in gene or miRNA expression in the old group are generally not 311 
unexpected. This is due to complexity of the ageing process, and comorbidities change 312 
occurring during ageing in the musculoskeletal system. The samples used in the old group 313 
were from two of the clusters.  Thus, whilst most of the miRNAs tested with qRT-PCR 314 
showed changes in the same direction as the microarray, some did not reach statistical 315 
significance.  316 
 317 
We believe that the analysis of young compared to ‘selection 3’ represents changes due to 318 
age and/or OA. These old samples represented those with the highest K&L scores compared 319 
to young. Within this dataset we identified 13 miRNAs known to affect the hallmarks of 320 
ageing, 11 of which were down regulated in ageing. These were for cellular senescence; Let-321 
7, miR-146b-5p; stem cell exhaustion; Let-7, miR-29b; altered nutrient sensing; miR-120, 322 
miR-320e; changes in gene regulation; miR-143, miR-193a, miR-200c, miR-29b; 323 
mitochondrial dysfunction; miR-145, miR- 349; DNA damage; miR-192, miR-24, miR-21; 324 
inflammageing; miR-21 and loss of telomeres; miR-34a [33]. Additionally, a number the DE 325 
miRNAs in this contrast had previously been identified in the pathogenesis of OA including 326 
miR-27b [38], miR-483 [39], miR-146 [40], miR-145 [41], and miR-675 [42]. In this study 327 
the expression of each of these miRNAs was reduced compared to young normal cartilage. 328 
Finally in this group were a number of miRNAs which roles in cartilage homeostasis 329 
including miR-337 [43], miR-302 [44], miR-181 [45], mir-193 [17], miR-135 [46], miR-24 330 
[20]. Additional work is required to decipher fully the role of this set of miRNAs in cartilage 331 
homeostasis, ageing and OA.  332 
 333 
Among microRNAs DE expressed in microarray and in the dependent cohort were miRNAs: 334 
miR-126, -200c, and -424 (Supplementary file 6), whereas miRNAs DE expressed in 335 
microarray and independent cohort included miRNAs: -21, -146, -181 (Figure 4). MiR-483 336 
was validated as DE expressed between young and old OA samples in both dependent and 337 
independent cohorts. Indeed, this miRNA has been previously shown to be involved in the 338 
pathogenesis of OA [38]. It was downregulated during ageing and OA in our studies, and 339 
others have shown its positive role in cartilage maintenance [38].  340 
Among interesting DE miRNAs in our study were miR-21, previously shown by us to be 341 
dysregulated in equine tissue during ageing [24], and  also classified as ‘inflamma-miR’ due 342 
to its major role in regulating inflammation [47]. MiR-181 demonstrated  to regulate 343 
chondrocyte apoptosis in OA  [48], and miR-424 previously suggested to play a role in OA 344 
[49] were also DE. Interestingly miR-424 was also DE in the young normal compared to old 345 
normal cohort and may also represent an age-related miR. 346 
 347 
MiR-200c has been linked to osteogenic differentiation and proinflammatory responses by 348 
targeting interleukin 6, 8 and chemokine (C-C motif) ligand. These are important mediators 349 
involved in OA inflammation [50]. In addition, miR-146a has been reported to play a role in 350 
cartilage homeostasis and preservation [51]. Yamasaki et al (2009) reported that expression 351 
of miR-146a was lower in late-OA cartilage compared to early stages This is in agreement 352 
with our results, where expression of miR-146a was significantly lower in the old OA donors 353 
from the dependent and independent cohorts [52]. 354 
 355 
Interestingly, our study has provided a new miRNA candidate, potentially regulating OA 356 
pathogenesis: miR-126. So far, little evidence exists on the role of miR-126 in joint pathology 357 
and OA. MiR-126 has been demonstrated to regulate angiogenesis and de novo 358 
vascularisation [53], as well as inflammation [54]. As cartilage is an avascular tissue, this 359 
may suggest a potential role of vascularisation, or lack of thereof in OA development. 360 
Previously increased miR-126 expression has been described as promoting matrix-dependent 361 
cell attachment and increased cell to cell interactions between perivascular and endothelial 362 
cells during angiogenesis. Here reduced miR-126 expression led to a less stable cell to matrix 363 
attachment network [55], in concordance with the tissue changes observed in OA. Moreover, 364 
Borgonio Cuadra et al has reported elevated levels of miR-126 in the plasma of OA patients 365 
[56]. However, as they mention, expression levels of intra and extracellular miRNAs may 366 
differ significantly.  Therefore it is not surprising that we found reduced miR-126 expression 367 
in knee cartilage from OA patients. Moreover, a few studies have linked miR-126 to ageing 368 
[57, 58]. Although, these studies were not relevant to cartilage homeostasis and OA, they 369 
provide indications of a possible role of miR-126 in cell ageing and senescence. Future 370 
functional studies will provide evidence on the extent to which miRNAs regulate OA 371 
development and the potential of miRNA-based interventions to ameliorate OA. 372 
 373 
5. Conclusions 374 
For the first time we demonstrated changes in miRNAs in human knee cartilage ageing and 375 
OA. These represent miRNAs with known roles in ageing and/or OA as well as novel 376 
candidates for further functional studies. Importantly, our work provides critical evidence on 377 
the potential function of biological processes of miRNAs in cartilage ageing and OA. Further 378 
work is ongoing to determine the functional significance of specific miRNA candidates 379 
identified in this study with the aim of providing candidates as diagnostic biomarkers and 380 
therapeutic targets for OA treatment.  381 
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Table 1. Table demonstrating the 20 DE miRNAs in young normal versus old OA cartilage.   521 
 522 




miR-126-3p -7.81 0.01 
miR-708-5p -5.72 0.01 
miR-489-3p -4.14 0.01 
miR-422a -4.14 0.03 
miR-378i -4.14 0.03 
miR-1273f -4.10 0.01 
miR-378f -4.05 0.03 
miR-150-5p -3.91 0.02 
miR-5585-3p -3.73 0.01 
miR-1273d -3.55 0.01 
miR-7111-5p -3.41 0.01 
miR-6875-5p -3.13 0.00 
miR-424-3p -2.58 0.03 
miR-6830-5p -2.16 0.04 
miR-6833-5p -1.89 0.03 
miR-6795-5p -1.80 0.02 
miR-4716-3p -1.74 0.02 
miR-4428 -1.68 0.02 
miR-5010-5p -1.29 0.02 
miR-486-5p 5.64 0.00 
FDR; false discovery rate. 523 
 524 
Table 2. Table demonstrating the 10 DE miRNAs in young normal versus old ‘selection 4’ 525 
cartilage. 526 





hsa-miR-486-5p 5.98 0.00 
hsa-mir-210 2.16 0.02 
hsa-miR-4521 1.94 0.04 
hsa-let-7a-1 0.93 0.04 
hsa-miR-423-5p 0.82 0.02 
hsa-miR-6795-5p -1.33 0.02 
hsa-miR-6774-5p -1.42 0.04 
hsa-miR-7111-5p -2.51 0.04 
hsa-miR-6824-5p -2.76 0.03 
hsa-miR-6875-5p -2.93 0.02 









Table 3. Summary of DE miRNAs detected by microarray analysis and selected for qRT-536 









let 7b-5p ↓ ↓ 
let 7f-1-3p ↑ ↑ 
21-5p ↓ ↓ 
126-3p ↓ ↓ 
146-5p ↓ ↓ 
150-5p ↓ ↓ 
181-5p ↓ ↓ 
200c-3p ↓ ↓ 
424-3p ↓ ↓ 
483-5p ↓ ↓ 
OOA; old osteoarthritic, YN; young normal. 539 
FIGURES 540 
Figure 1. Variation data between the expressions for 12 microarray samples. (A) The heat 541 
map of hierarchical clusters of correlations among samples. Pearson’s correlation coefficients 542 
were computed using logarithm transformed miRNA expression data from all miRNA probes 543 
that were detected. (B) A 2-D PCA plot of the second and third components from PCA of 544 
logarithm-transformed miRNA abundance data. The Kellgren and Lawrence scores (K&L) 545 
for the groups are shown on the PCA plot. Abbreviations; H; young, O; old. 546 
 547 




Figure 2. Cartilage expression profiling using an MA plot. The MA plot contrasts the log2 552 
Fold change (log2FC) against the mean intensity of all 12 arrays. The coloured spots 553 
represent DE small RNAs (FDR <0.05); green dots reduced expression in old OA samples 554 
and red dots increased expression in old OA samples. 20 miRs were significantly 555 
dysregulated; one increased in OA and 19 decreased in OA.  556 
 557 
Figure 3. The position of the DE miRNAs in the chondrocyte expression network. Gene 558 
ontology biological processes associated with dysregulated miRNA targets were identified 559 
following TargetScan filter module in IPA. ToppGene was used to perform functional 560 
enrichment analysis on predicted miRNA targets to highlight biological processes most 561 
significantly affected by dysregulated miRNA-mRNA interactions.  GO terms (FDR < 0.05) 562 
were summarized and visualised using REViGO and Cytoscape. Allowed similarity setting in 563 
Revigo was medium. The main clusters of biological processes significantly influenced by 564 
dysregulated miRs in (A) all young compared to all old samples and (B) all young samples 565 













Figure 4. Validation of microarray results using qRT-PCR in an independent cohort. (A) 579 
Relative expression of miRNAs between young normal and old OA cartilage. qRT-PCR 580 
results show relative expression  normalised to Rnu-6 gene, young samples n=7-8, old OA 581 
samples n=5-7. (B) Relative expression of miRNAs between young normal and old normal 582 
samples in an independent cohort. Results show young normal samples (n=8) and old normal 583 
samples (n=3-4). Mann-Whitney test was performed using GraphPad Prism version 7.03; p 584 
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